Skip to content

Electroacupuncture intervention for gastrointestinal dysfunction after chemotherapy in colorectal cancer: a randomized controlled trial

A randomized controlled trial on the effectiveness and safety of acupuncture in the treatment of gastrointestinal dysfunction after chemotherapy for colorectal cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2200006415
Enrollment
Unknown
Registered
2022-08-01
Start date
2022-07-28
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal cancer

Interventions

Acupuncture group:Acupuncture
Sham acupuncture group:Sham acupuncture

Sponsors

Chengdu University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: (1) The age is 18 years old = age = 75 years old, male or female; (2) The diagnosis of primary colon cancer or primary high rectal cancer was confirmed by colonoscopy and histopathological biopsy; (3) At least one cycle of chemotherapy has been completed, and symptoms related to gastrointestinal dysfunction, including nausea, vomiting, abdominal distension, diarrhea, constipation, etc., have been completed after chemotherapy; any item in the gastrointestinal symptom grading scale has a score of 2 or more . (4) Karnofsky score = 60 points, or ECOG physical condition score = 1 point; (5) Have not received acupuncture and moxibustion in the past 3 months and have not participated in other clinical investigators in the past 3 months; (6) Gastrointestinal dysfunction caused by non-opioid drugs or metabolic imbalance; (7) Sign the informed consent form and voluntarily participate in this researcher.

Exclusion criteria

Exclusion criteria: (1) Those who have undergone total colorectal resection; (2) Combined with severe heart and cerebrovascular diseases; (3) Combined with abnormal coagulation function; (4) Consciousness is unclear, unable to express subjective discomfort symptoms and mentally ill patients; (5) Long-term use of laxatives, or taking drugs that affect gastrointestinal function and long-term bed rest.

Design outcomes

Primary

MeasureTime frame
Gastrointestinal symptom rating scale;

Secondary

MeasureTime frame
Patient Self-Reported Outcomes;SDS (Self-Rating Depression Scale);SAS (Self-Rating Anxiety Scale);Evaluation of the Functional Assessment of Cancer Therapy-Colorectal (V4.0);

Countries

China

Contacts

Public ContactLiang Fanrong
acuresearch@126.com+86 13608058216

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026